论文部分内容阅读
[目的]探讨康复新液联合奥美拉唑治疗反流性食管炎的促进协同作用及安全性。[方法]将80例反流性食管炎患者随机分为2组,对照组40例,治疗组40例。对照组仅给予奥美拉唑治疗,治疗组给予康复新液联合奥美拉唑口服。2组疗程均为4周。疗程结束后进行胃镜改变和临床症状疗效的评定。[结果]治疗4周后治疗组内镜下减轻总有效率和临床症状缓解总有效率均优于对照组,2组比较差异有统计学意义(P<0.05)。[结论]康复新液联合奥美拉唑治疗反流性食管炎疗效良好,胜于单纯口服奥美拉唑,值得临床推广。
[Objective] To investigate the synergistic effect and safety of Kangfuxin solution combined with omeprazole in the treatment of reflux esophagitis. [Methods] 80 patients with reflux esophagitis were randomly divided into two groups, the control group of 40 cases, the treatment group of 40 cases. The control group was given only omeprazole treatment, the treatment group was given Kangfuxin solution omeprazole orally. The two courses of treatment were 4 weeks. After the end of the course of gastroscopic changes and the evaluation of clinical efficacy. [Result] After 4 weeks of treatment, the total effective rate of endoscopic treatment and the total effective rate of clinical symptom relief in the treatment group were better than those in the control group. The difference between the two groups was statistically significant (P <0.05). [Conclusion] Kangfuxin and omeprazole are effective in treatment of reflux esophagitis, which is better than oral omeprazole alone and worthy of clinical promotion.